VUMC News and Communications

February 1, 2012

Treatment window for genetic disorder

Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.

By VUMC News and Communications

February 1, 2012

Drugs reverse lung cancer cell changes

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.

By VUMC News and Communications

January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.

By VUMC News and Communications

January 26, 2012

“My Health Chat” takes on autism, other developmental disabilities

By VUMC News and Communications

January 26, 2012

Tenth annual Dance Marathon set for Feb. 17-18

By VUMC News and Communications

January 25, 2012

Protein repairs esophageal DNA damage

A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.